Literature DB >> 12040353

The heart in neurofibromatosis type 1: an echocardiographic study.

Michele Adolfo Tedesco1, Giovanni Di Salvo, Francesco Natale, Valeria Pergola, Elvira Calabrese, Carolina Grassia, Gennaro Ratti, Diana Iarussi, Aldo Iacono, Raffaele Calabrò, Giuliana Lama.   

Abstract

BACKGROUND: Comprehensive data are unavailable for cardiac abnormalities in patients with neurofibromatosis type 1 (NF1). The goal of this study was to evaluate the prevalence of cardiovascular abnormalities with echocardiography with color Doppler scan (ECHO) in a large, consecutive series of patients with NF1.
METHODS: We studied 48 patients with NF1 (mean age, 10 years). Thirty healthy subjects comparable for age and sex served as the control group. All ECHO studies were performed by the same cardiologist and reviewed by a second cardiologist blinded to the physical findings of the subjects.
RESULTS: Cardiac abnormalities were found in 13 of the 48 young patients (27%). A secundum atrial septal defect with a left to right shunt was found in 2 children. ECHO evidence of mild left pulmonary artery stenosis was found in 1 participant. A moderate coarctation of the thoracic aorta was found in 1 patient. ECHO criteria for mitral valve prolapse and evidence of trivial mitral regurgitation with myxomatous mitral valve was present in 1 case. Mild mitral regurgitation was found in 2 patients. A regurgitant mild flow signal was detected from the aortic valve in 2 subjects. Atrial septal aneurysm was found in 2 patients without patent foramen ovale. Two patients had septal to posterior left ventricular free wall ratio greater than 1.5, suggesting hypertrophic cardiomyopathy.
CONCLUSION: This is the first attempt to evaluate the prevalence of cardiovascular abnormalities in patients with NF1 with ECHO. The study's most striking finding is the high prevalence of cardiovascular abnormalities. Congenital lesions have potential long-term hemodynamic consequences that justify an early diagnosis. Thus, a cardiologic assessment at regular intervals, including ECHO study, is mandatory for patients with NF1.

Entities:  

Mesh:

Year:  2002        PMID: 12040353     DOI: 10.1067/mhj.2002.122121

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  Perioperative management of neurofibromatosis type 1.

Authors:  Charles J Fox; Samir Tomajian; Aaron J Kaye; Stephanie Russo; Jacqueline Volpi Abadie; Alan D Kaye
Journal:  Ochsner J       Date:  2012

2.  Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction.

Authors:  Junwang Xu; Fraz A Ismat; Tao Wang; Min Min Lu; Nicole Antonucci; Jonathan A Epstein
Journal:  Circ Res       Date:  2009-07-02       Impact factor: 17.367

3.  Blood pressure and cardiovascular involvement in children with neurofibromatosis type1.

Authors:  Giuliana Lama; Luisa Graziano; Elvira Calabrese; Carolina Grassia; Pier Francesco Rambaldi; Fabrizio Cioce; Michele Adolfo Tedesco; Giovanni Di Salvo; Maria Esposito-Salsano
Journal:  Pediatr Nephrol       Date:  2004-02-26       Impact factor: 3.714

4.  Prevalence, Type, and Molecular Spectrum of NF1 Mutations in Patients with Neurofibromatosis Type 1 and Congenital Heart Disease.

Authors:  Valentina Pinna; Paola Daniele; Giulio Calcagni; Lucio Mariniello; Roberta Criscione; Chiara Giardina; Francesca Romana Lepri; Hossein Hozhabri; Angela Alberico; Stefania Cavone; Annunziata Tina Morella; Roberta Mandile; Francesca Annunziata; Niccolò Di Giosaffatte; Maria Cecilia D'Asdia; Paolo Versacci; Rossella Capolino; Pietro Strisciuglio; Sandra Giustini; Daniela Melis; Maria Cristina Digilio; Marco Tartaglia; Bruno Marino; Alessandro De Luca
Journal:  Genes (Basel)       Date:  2019-09-04       Impact factor: 4.096

5.  Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Authors:  Christina Bergqvist; Amandine Servy; Laurence Valeyrie-Allanore; Salah Ferkal; Patrick Combemale; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

6.  Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?

Authors:  Adila Alkindy; Nadia Chuzhanova; Usha Kini; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2012-08-13       Impact factor: 4.639

7.  Unroofed coronary sinus in a patient with neurofibromatosis type 1.

Authors:  Luciano Pereira Bender; Maria Rita F Meyer; Rafael Fabiano M Rosa; Rosana Cardoso M Rosa; Patrícia Trevisan; Paulo Ricardo G Zen
Journal:  Rev Paul Pediatr       Date:  2013-12

8.  Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study.

Authors:  Jussi Leppävirta; Roope A Kallionpää; Elina Uusitalo; Tero Vahlberg; Minna Pöyhönen; Juha Peltonen; Sirkku Peltonen
Journal:  Orphanet J Rare Dis       Date:  2018-01-15       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.